Nonprofit · EIN 74-3100945
VIVA PHYSICIANS INC
Tax-exempt · PALM SPRINGS, CA 92262
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2025 | 990 | $6,900,317 | $5,745,007 | $1,155,310 | $29,113,438 | $1,387,081 | $27,726,357 |
| December 31, 2024 | 990 | $6,330,006 | $5,339,936 | $990,070 | $26,199,265 | $970,940 | $25,228,325 |
| December 31, 2023 | 990 | $5,950,071 | $4,827,351 | $1,122,720 | $24,393,940 | $826,456 | $23,567,484 |
Financial details: 990 for the year ended December 31, 2025
Revenue
- Contributions, gifts and grants
- $2,312,500
- Program service revenue
- $3,847,039
- Investment income
- $740,299
- Royalties
- $479
- Net gain from sales of assets
- $7,238
- Other revenue
- $479
Expenses
- Grants and similar amounts paid
- $511,000
- Compensation of officers, directors and key employees
- $800,085
- Other salaries and wages
- $765,558
- Salaries, compensation and benefits (total)
- $1,720,412
- Professional fundraising fees
- $0
- Legal fees
- $3,386
- Accounting fees
- $57,635
- Occupancy
- $25,374
- Travel
- $665,624
- Depreciation
- $12,350
- Program services (functional)
- $5,350,537
- Management and general (functional)
- $376,455
- Fundraising (functional)
- $18,015
Balance sheet and other
- Total assets, start of year
- $26,199,265
- Total assets, end of year
- $29,113,438
- Total liabilities, end of year
- $1,387,081
- Net assets, end of year
- $27,726,357
- Land, buildings and equipment
- $71,075
- Publicly traded securities
- $16,511,345
- Net assets without donor restrictions
- $27,644,078
- Net assets with donor restrictions
- $82,279
- Gross receipts
- $7,383,037
- Employees
- 7
- Volunteers
- 0
- Year formed
- 2003
- State of legal domicile
- MA
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| REBECCA HALL | EXECUTIVE DIRECTOR Officer | 40 | $425,659 | $29,238 |
| CHRISTOPHER EBBE | DIRECTOR OF PROGRAMS Highest-paid employee | 40 | $285,538 | $33,310 |
| THERESA KINANE | DIRECTOR OF FINANCE & LOGISTICS Highest-paid employee | 40 | $225,049 | $19,018 |
| BRITA THORNE | FACULTY MANAGER Highest-paid employee | 40 | $117,394 | $12,861 |
| SAHER SABRI MD | BOARD PROGRAM CHAIR Trustee or director, Officer | 3 | $54,250 | $0 |
| NITEN SINGH MD | BOARD PRESIDENT Trustee or director, Officer | 3 | $49,000 | $0 |
| PARAG PATEL MD | BOARD SECRETARY/TREASURER Trustee or director, Officer | 3 | $40,000 | $0 |
| EHRIN ARMSTRONG MD | BOARD TRUSTEE Trustee or director | 3 | $25,000 | $0 |
| CHRISTOPHER METZGER MD | BOARD TRUSTEE Trustee or director | 3 | $25,000 | $0 |
| RAGHU KOLLURI MD | BOARD TRUSTEE Trustee or director | 3 | $25,000 | $0 |
| SEAN P LYDEN MD | BOARD TRUSTEE Trustee or director | 3 | $25,000 | $0 |
| JOSHUA A BECKMAN MD | BOARD TRUSTEE Trustee or director | 3 | $23,000 | $0 |
| KATHLEEN GIBSON MD | BOARD PROGRAM CHAIR Trustee or director, Officer | 3 | $22,438 | $0 |
| ERIC SECEMSKY MD | BOARD TRUSTEE Trustee or director | 3 | $21,000 | $0 |
| VENITA CHANDRA MD | BOARD TRUSTEE Trustee or director | 3 | $18,750 | $0 |
1 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| BRIAN DERUBERTIS MD | BOARD TRUSTEE Trustee or director | 3 | $16,750 |
990 for the year ended December 31, 2024: 16 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| REBECCA HALL | EXECUTIVE DIRECTOR Officer | 40 | $407,452 | $30,468 |
| CHRISTOPHER EBBE | DIRECTOR OF PROGRAMS Highest-paid employee | 40 | $276,633 | $30,908 |
| THERESA KINANE | DIRECTOR OF FINANCE & LOGISTICS Highest-paid employee | 40 | $210,400 | $17,653 |
| BRITA THORNE | FACULTY MANAGER Highest-paid employee | 40 | $106,040 | $11,986 |
| RAGHU KOLLURI MD | BOARD PRESIDENT Trustee or director, Officer | 3 | $69,250 | $0 |
| SAHER SABRI MD | BOARD PROGRAM CHAIR Trustee or director, Officer | 3 | $51,125 | $0 |
| VENITA CHANDRA MD | BOARD SECRETARY/TREASURER Trustee or director, Officer | 3 | $26,125 | $0 |
| JOSHUA A BECKMAN MD | BOARD TRUSTEE Trustee or director | 3 | $25,000 | $0 |
| SEAN P LYDEN MD | BOARD TRUSTEE Trustee or director | 3 | $25,000 | $0 |
| CHRISTOPHER METZGER MD | BOARD TRUSTEE Trustee or director | 3 | $25,000 | $0 |
| PARAG PATEL MD | BOARD TRUSTEE Trustee or director | 3 | $25,000 | $0 |
| ERIC SECEMSKY MD | BOARD TRUSTEE Trustee or director | 3 | $25,000 | $0 |
| NITEN SINGH MD | BOARD TRUSTEE Trustee or director | 3 | $25,000 | $0 |
| EHRIN ARMSTRONG MD | BOARD TRUSTEE Trustee or director | 3 | $24,875 | $0 |
| MAUREEN KOHI MD | BOARD PROGRAM CHAIR Trustee or director, Officer | 3 | $8,750 | $0 |
| KATHLEEN GIBSON | BOARD TRUSTEE Trustee or director | 3 | $7,250 | $0 |
990 for the year ended December 31, 2023: 15 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| REBECCA HALL | EXECUTIVE DIRECTOR Officer | 40 | $396,595 | $28,856 |
| CHRISTOPHER EBBE | DIRECTOR OF PROGRAMS Highest-paid employee | 40 | $251,327 | $35,021 |
| THERESA KINANE | DIRECTOR OF FINANCE & LOGISTICS Highest-paid employee | 40 | $149,231 | $7,148 |
| RAGHU KOLLURI MD | BOARD PRESIDENT Trustee or director, Officer | 3 | $70,000 | $0 |
| NITEN SINGH MD | BOARD PROGRAM CHAIR Trustee or director, Officer | 3 | $45,000 | $0 |
| SAHER SABRI MD | BOARD TRUSTEE Trustee or director | 3 | $28,500 | $0 |
| JOSHUA A BECKMAN MD | BOARD TRUSTEE Trustee or director | 3 | $25,000 | $0 |
| SEAN P LYDEN MD | BOARD TRUSTEE Trustee or director | 3 | $25,000 | $0 |
| CHRISTOPHER METZGER MD | BOARD TRUSTEE Trustee or director | 3 | $25,000 | $0 |
| ERIC SECEMSKY MD | BOARD TRUSTEE Trustee or director | 3 | $25,000 | $0 |
| EHRIN ARMSTRONG MD | BOARD TRUSTEE Trustee or director | 3 | $23,500 | $0 |
| VENITA CHANDRA MD | BOARD SECRETARY/TREASURER Trustee or director, Officer | 3 | $22,813 | $0 |
| MAUREEN KOHI MD | BOARD PROGRAM CHAIR Trustee or director, Officer | 3 | $22,750 | $0 |
| PETER SCHNEIDER MD | BOARD TRUSTEE (THRU 12/23) Trustee or director | 3 | $22,250 | $0 |
| PARAG PATEL MD | BOARD TRUSTEE Trustee or director | 3 | $21,500 | $0 |
Address and contacts
- Address (IRS master file)
- 400 S FARRELL DR STE B120, PALM SPRINGS, CA 92262-7937
- Principal officer (990 for 2025)
- REBECCA HALL, 400 S FARRELL DRIVE B120, PALM SPRINGS, CA 92262
- Signed the 990
- REBECCA HALL, EXECUTIVE DIRECTOR
- Phone
- (408) 513-3241
- Website
- HTTPS://VIVA-FOUNDATION.ORG
- Return prepared by
- ARMANINO ADVISORY LLC
California records
California keeps its own records of charities and corporations. Search them by EIN 74-3100945 or by the name VIVA PHYSICIANS INC.
- Attorney General, Registry of Charities and Fundraisers
- Registration status and filed reports (CT-TR-1, RRF-1)
- Secretary of State, bizfile Online
- Corporation status, entity number, agent for service
- Franchise Tax Board
- Entity status letter (state tax exemption, good standing)
Mission
TO SYNERGIZE THE COLLECTIVE TALENTS OF THESE RECOGNIZED EXPERTS TO PROMOTE AWARENESS AND INNOVATIVE THERAPEUTIC OPTIONS FOR VASCULAR DISEASE
Program accomplishments
- EDUCATIONTHE ORGANIZATION SPONSORS VASCULAR INTERVENTIONAL ADVANCES ("VIVA"), THE GLOBAL EDUCATION COURSE FOR VASCULAR MEDICINE AND INTERVENTION. VIVA IS CONDUCTED ANNUALLY IN LAS VEGAS, NEVADA AND ON A SMALLER SCALE WITH OTHER NONPROFIT ORGANIZATIONS IN A COLLABORATIVE ROLE BOTH DOMESTICALLY AND WORLDWIDE. IN 2025, THE ANNUAL CONFERENCE WAS HOSTED LIVE AND VIRTUALLY, AND SEVERAL EDUCATIONAL WEBINARS WERE HELD THROUGHOUT THE YEAR.VIVA IS SPONSORED BY VPI AND CONTRACTS WITH AN ACCREDITED CONTINUING MEDICAL EDUCATION ("CME") PROVIDER (CONTINUED ON SCHEDULE O)TO APPROVE CREDITS FOR PHYSICIAN ATTENDEES NURSES, TECHS, AND OTHER HEALTHCARE PROFESSIONALS. VIVA FURTHERS VPL'S EXEMPT PURPOSE AS BOTH AN ACCREDITED CONTINUING MEDICAL EDUCATION PROGRAM AND A FORUM FOR PROMOTING THE LATEST RESEARCH FINDINGS AND TECHNOLOGY IN THE FIELD OF VASCULAR MEDICINE AND INTERVENTION.IN 2015, VIVA ADDED A TWO-DAY PROGRAM, THE VEINS (VENOUS ENDOVASCULAR INTERVENTIONAL STRATEGIES), FOCUSED EXCLUSIVELY ON TREATING PATIENTS WITH VENOUS DISEASE. THIS COURSE IS HELD ANNUALLY THE TWO DAYS PRECEDING THE VIVA CONFERENCE. VPI HAS SUPPORTED A MULTIDISCIPLINARY FELLOWSHIP FOR SEVERAL YEARS. IN THE PAST SEVEN YEARS, ADDITIONAL OPPORTUNITIES FOR TRAINING FELLOWS HAVE BEEN INCORPORATED INTO THE ANNUAL VIVA CONFERENCE. BEGINNING IN 2018, VIVA PARTNERED WITH THE AMERICAN HEART ASSOCIATION TO PROVIDE RESEARCH GRANTS FOR FELLOWS AND PLANS TO CONTINUE THIS COLLABORATION THROUGH 2027, AS WELL AS A GRANT FOR A COLLABORATIVE SCIENCES AWARD FOR PATIENT-ORIENTED AND CLINICAL RESEARCH IN VASCULAR SCIENCE.VIVA IS FUNDED PRIMARILY THROUGH UNRESTRICTED EDUCATIONAL GRANTS FROM COMMERCIAL SUPPORTERS IN ACCORDANCE WITH STANDARDS OF THE AMERICAN COUNCIL FOR CONTINUING MEDICAL EDUCATION ("ACCME"). VIVA ALSO GENERATES FUNDS THROUGH REGISTRATION AND TUITION PAYMENTS FROM THE CONFERENCE ATTENDEES.VPI STRIVES TO BE THE PREMIER EDUCATOR IN THE FIELD OF VASCULAR MEDICINE AND INTERVENTION AND TO ASSOCIATE THE NAME "VIVA" WITH CUTTING EDGE AND STATE-OF-THE-ART PROGRAMS THAT SERVE THE PUBLIC GOOD BY PROMOTING ADVANCES IN TREATMENT OF PERIPHERAL VASCULAR DISEASE. IN 2012, VPI EXPANDED ITS INTERNATIONAL EDUCATIONAL OPPORTUNITIES BY COLLABORATING WITH INTERNATIONAL ORGANIZATIONS TO PROVIDE STATE OF THE ART LEARNING MODALITIES AND CUTTING-EDGE PROGRAMS IN COUNTRIES SUCH AS BRAZIL, GERMANY, GREAT BRITAIN, ISRAEL AND CHINA.IN 2014, VPI LAUNCHED A VIRTUAL VIV A APPLICATION THAT MADE IT POSSIBLE FOR INTERNATIONAL AND MILITARY PHYSICIANS TO PARTICIPATE IN THE ANNUAL VIV A CONFERENCE REMOTELY. VIVA OFFERS COMPLIMENTARY ACCESS AND/OR DEEP DISCOUNTS TO EDUCATIONAL CONTENT THROUGH THE VIRTUAL VIVA APP TO INTERNATIONAL PHYSICIANS AS WELL AS ALL ACTIVE MILITARY PHYSICIANS.IN 2025, VPI ENTERED INTO AN AGREEMENT WITH THE MINNEAPOLIS RADIOLOGY AND VASCULAR RESEARCH FOUNDATION TO ASSUME MANAGEMENT OF CARVE - CLINICALLY RELEVANT VASCULAR & ENDOVASCULAR SURGERY, AN EDUCATIONAL CONFERENCE THAT TOOK PLACE FROM MARCH 8, 2026 THROUGH MARCH 11, 2026.RESEARCHVPI SPONSORS RESEARCH AND PIONEERING THERAPY IN THE FIELD OF VASCULAR MEDICINE. VPI RECEIVES GRANTS FROM INDUSTRY AS WELL AS CONTRIBUTIONS FROM PRIVATE INDIVIDUALS IN SUPPORT OF PVD (PERIPHERAL VASCULAR DISEASE) RESEARCH.VPI HAS MANAGED SEVERAL FOOD AND DRUG ADMINISTRATION ("FDA") APPROVED STUDIES RELATED TO PVD TREATMENT. THESE TRIALS FOLLOW GOOD CLINICAL PRACTICE ("GCP") PROTOCOLS AND REQUIRE STRICT INSTITUTIONAL REVIEW BOARD ("IRB") APPROVAL AT EACH SITE. VIVA HAS ALSO PROVIDED SUPPORT FOR NIH APPROVED CLINICAL TRIALS IN THE VASCULAR AND VEINS SPACE.ADVOCACYAS PART OF VPI'S STRATEGIC PLAN, PATIENT CARE ADVOCACY PROGRAMS ARE DESIGNED TO ADVANCE THE FIELD OF VASCULAR DISEASE CARE AND ENGAGE THOUGHT LEADERS AND GOVERNMENT AGENCIES, INCLUDING THE U.S. FOOD AND DRUG ADMINISTRATION (FDA) AND THE CENTERS FOR MEDICARE & MEDICAID SERVICES (CMS).THE FIRST ADVOCACY PROGRAM WAS HELD IN APRIL 2016 AND FOCUSED ON THE GLOBAL MANAGEMENT OF CRITICAL LIMB ISCHEMIA (CLI), ONE OF THE MOST CHALLENGING VASCULAR DISORDERS. A SECOND VASCULAR DISEASE FORUM WAS CONVENED IN MAY 2018, FOCUSING ON THE TREATMENT AND MANAGEMENT OF CAROTID ARTERY DISEASE. A SUBSEQUENT FORUM IN FEBRUARY 2019 ADDRESSED A META-ANALYSIS EVALUATING THE SAFETY OF PACLITAXEL. AS PART OF THIS EFFORT, VPI LED THE ANALYSIS OF PATIENT-LEVEL DATA TO ADDRESS QUESTIONS RELATED TO PATIENT SAFETY; THE FINDINGS WERE SUBSEQUENTLY PUBLISHED IN THE PEER-REVIEWED JOURNAL CIRCULATION.IN 2022, VPI SPONSORED AN ADDITIONAL FORUM ADDRESSING KEY ISSUES RELATED TO VENOUS STENTING AND THROMBECTOMY, WHICH RESULTED IN A PUBLISHED PAPER. IN 2024, VPI HOSTED A VASCULAR LEADERS FORUM FOCUSED ON CHRONIC LIMBTHREATENING ISCHEMIA (CLTI), WHICH PRODUCED TWO PUBLISHED ARTICLES: COLLABORATION IN CONTEMPORARY CLTI CARE AND DESIGNING CLTI CLINICAL TRIALS.THE 2025 FORUM FOCUSED ON ENDOVASCULAR REPAIR FOR AORTIC ANEURYSMS, WITH TWO WHITE PAPERS EXPECTED TO BE PUBLISHED: (1) A PAPER ADDRESSING THE HISTORY AND TERMINOLOGY SURROUNDING "ENDOLEAK, AND (2) A PAPER FOCUSED ON ADVANCING TREATMENT APPROACHES IN THE COMPLEX AORTIC DISEASE SPACE.Expenses $5,350,537 · grants $511,000 · revenue $3,847,039
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | 990 on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 74-3100945
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2006
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Education (B60)
- Assets (IRS master file)
- $29,113,438
- Income (IRS master file)
- $7,383,037
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2025 | $6,900,317 | $5,745,007 | $29,113,438 | XML |
| 990 | December 2024 | $6,330,006 | $5,339,936 | $26,199,265 | XML |
| 990 | December 2023 | $5,950,071 | $4,827,351 | $24,393,940 | XML |
| 990 | December 2022 | $5,717,586 | $5,367,452 | $22,100,991 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 74-3100945).
Questions about VIVA PHYSICIANS INC
- What is the EIN of VIVA PHYSICIANS INC?
- The employer identification number (EIN) of VIVA PHYSICIANS INC is 74-3100945.
- Is VIVA PHYSICIANS INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2006.
- Are donations to VIVA PHYSICIANS INC tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does VIVA PHYSICIANS INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of VIVA PHYSICIANS INC due?
- The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did VIVA PHYSICIANS INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2025.
- Who is the principal officer of VIVA PHYSICIANS INC?
- The 990 for the year ended December 31, 2025 names REBECCA HALL.
- Who are the officers and directors of VIVA PHYSICIANS INC?
- The 990 for the year ended December 31, 2025 lists 16 people; 16 received compensation from the organization, the highest $425,659 (REBECCA HALL, EXECUTIVE DIRECTOR).
- How much revenue does VIVA PHYSICIANS INC have?
- On its 990 for the year ended December 31, 2025 it reported revenue of $6,900,317, expenses of $5,745,007 and total assets of $29,113,438 at year end.
Other nonprofits in PALM SPRINGS
- PALM SPRINGS CULTURAL CENTER EIN 55-0914693 · last filed 990 for 2024
- DPMG HEALTH EIN 85-3624586 · last filed 990 for 2025
- PALM SPRINGS LEATHER ORDER OF THE DESERT EIN 86-1050469 · last filed 990 for 2025
- PALM SPRINGS PUBLIC LIBRARY FOUNDATION EIN 47-2910849 · last filed 990 for 2025
- LEADERSHIP COACHELLA VALLEY EIN 33-0914378 · last filed 990-EZ for 2025
- RAYMOND CREE MIDDLE SCHOOL BAND BOOSTERS EIN 51-0617624 · last filed 990-EZ for 2025
- NEGRO ACADEMIC SCHOLARSHIP FUND EIN 23-7253537 · last filed 990-EZ for 2024
- PTA CALIFORNIA CONGRESS OF PARENTS TEACHERS & STUDENTS INC EIN 20-8686149 · last filed 990-EZ for 2025